According to Onconova Therapeutics's latest financial reports the company has A$26.12 Million in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-12-31 | A$56.95 M | -25.02% |
2021-12-31 | A$75.96 M | 207.01% |
2020-12-31 | A$24.74 M | -23.77% |
2019-12-31 | A$32.45 M | 34.75% |
2018-12-31 | A$24.08 M | 367.35% |
2017-12-31 | A$5.15 M | -82.68% |
2016-12-31 | A$29.75 M | 9.49% |
2015-12-31 | A$27.17 M | -48.96% |
2014-12-31 | A$53.25 M | -52.5% |
2013-12-31 | A$0.11 B | 42.91% |
2012-12-31 | A$78.45 M | 2864.99% |
2011-12-31 | A$2.64 M |